A population-based study was performed in order to and IRR correlated negatively with BP in women but correlations disappeared after age adjustment. The 23 study the interrelationships of the circulating components of the renin-angiotensin system during basal conwomen on oestrogen medication did not differ from the remaining 81 with respect to age (P = 0.6), IRR (P = 0.96) ditions and their relations to blood pressure (BP), age and gender. One hundred and four women and 95 men, or angiotensin II (P = 0.4) levels, but PRA was higher (2.2 ± 1.4 ng Ang I/ml/h and 1.5 ± 0.9 ng Ang I/ml/h, 18-70 years old, evenly age distributed and randomly selected from the population of Linköping, Sweden, parrespectively, P = 0.004). PRA (r = 0.38, P Ͻ 0.0001) and IRR (r = 0.49, P Ͻ 0.0001) correlated positively with the ticipated. Venous blood was drawn at 08.00 hours and ambulatory BP recording was then performed. Serum levels of angiotensin II. In conclusion the fact that PRA, but not IRR, declined with age and was higher among angiotensin-converting enzyme (ACE) activity correlated with plasma angiotensin II (r = 0.20, P = 0.004), but oestrogen-treated women, although angiotensin II was unaffected suggests IRR to be a more robust marker of when calculated separately according to gender, the correlation remained significant only in men (r = 0.33, P angiotensin II levels than is PRA in a population-based setting. ACE correlates positively with angiotensin II in = 0,001). Plasma renin activity (PRA) correlated negatively with age (r = −0.30, P Ͻ 0.0001), but immunoreacmen. tive active renin (IRR) and angiotensin II did not. PRA
Introduction molecule itself (immunoreactive active renin, IRR)
The end product of the renin-angiotensin-system with the use of a monoclonal antibody-based tech-(RAS), angiotensin II, has vasoconstrictive, sodium nique. 10 This makes it interesting to study if there and fluid retaining properties. It also causes are differences between IRR, ie, plasma renin conhypertrophy of cardiac myocytes and hyperplasia of centration, and PRA with regard to their relation to cardiac fibroblasts. 1 Recent reports show that the levels of plasma angiotensin II. According to most D/D genotype of the insertion/deletion (I/D) polystudies 24-h ambulatory blood pressure (ABP) corremorphism of the angiotensin-converting enzyme lates better than clinic blood pressure (CBP) with (ACE) allele, which is linked to higher serum ACEleft ventricular hypertrophy 11,12 which might be also activity 2 is a marker of poor cardiovascular progtrue also for the association between the RAS and nosis, [3] [4] [5] although this has not been the case in all ABP. The aim of our study was to study interpopulations studied. 6 High plasma ACE levels are relationships of the circulating components of the associated with carotid-wall thickening. 7 This is RAS during basal conditions and their relations to supposedly caused by higher angiotensin II levels ABP, CBP, age and gender. or increased breakdown of kinins, which raises the question whether the ACE-activity level is also a
Subjects and methods
determinant of the angiotensin II production rate.
The level of plasma renin activity (PRA) is depenSubjects dent on the angiotensinogen concentration in the sample. 8, 9 This could possibly hamper its ability to The study was approved by the local ethics committruly reflect angiotensin II levels. It is now possible tee and performed according to the declaration of Helsinki. Participants were sent an invitation by mail using addresses randomly obtained from the letter also included a questionnaire in which sub-taking. The aim was to evaluate approximately 100 a supine diastolic CBP of у90 to Ͻ95 mm Hg. Another seven men had supine diastolic CBP у95 men and 100 women aged 20 to 70 years, evenly distributed in each 10-year age group. The only to р100. There were no subjects with diastolic CBP greater than 100 mm Hg. Twenty-three women were exclusion criterion was treated hypertension. To achieve this we consecutively invited 367 subjects.
on oral oestrogen medication either as anticonception (n = 9) or as supplementation (n = 14). There Of the 367 invited subjects, 31 were excluded because they were taking antihypertensive mediwas no age difference among women on oestrogen (44 ± 15 years) or without (46 ± 15 years, P = 0.6 for cation. Of the 336 subjects eligible for the study 224 visited our clinic; a participation rate of 67% (men: difference) this medication. 64%, women: 69%). Non-participation was most common among men 30-39 years of age Assay methods (participation rate, 55%) but in all other age-categories, divided by 10 year intervals and according to Plasma for analysis of PRA, IRR and angiotensin II gender, participation rate was at least 64%. Women was immediately separated by centrifugation and 40-49 and 50-59 years of age had a participation stored at −20°C (IRR and PRA) or −70°C (angiotensin rate of 73% and 76%, respectively. The majority of II) until analysis. PRA was determined as generated non-participants were contacted by phone and the angiotensin I which was measured by radiomost common reason for not participating was 'lack immuno-assay (RIA) after an hour of incubation at of time'. pH 6.0. Six standards between 0.1 and 5 ng Ang The subjects arrived at the clinic at 08.00 after an I/ml/h were used and 50% binding was seen at overnight fast from 22.00. Standardized CBP was approximately 1.9 ng Ang I/ml/h, the method has measured by either of two trained nurses with a merbeen described in detail elsewhere. 13 Plasma angiocury sphygmomanometer. They used armcuffs with tensin II was measured by RIA mainly as described a 12 cm width if arm circumference was р32 cm.
earlier, 14 the method being modified by the use of In subjects with Ͼ32 cm arm circumference either a Sep-Pak C18 cartridges for the extraction of plasma. coneshaped cuff with a width of 14 cm, or an ordi-
The cross-reactivity of the anti-serum with angiotennary 15 cm wide armcuff, depending on the subsin I was 0.2%. Total coefficient of variation (CV), ject's shape of the upper arm, was used. There were ie, intra-+ inter-assay coefficients of variation, for no subjects in this study with upper arm circumfer-PRA and angiotensin II was р12% and р12%, ence Ͻ25 cm. Supine and sitting BP were measured respectively. IRR was measured using a kit from the after resting for 5 min in each position, standing BP Pasteur Institute in which the second antibody is was measured after 2 min. Korotkoff sounds phase directed against the active site of the renin mol-I and V were used to define systolic and diastolic ecule. 10 CV for IRR was р10%. Serum ACE was BP, respectively. A total of 160 ml venous blood was determined using the artificial substrate 3-(2-furylthen drawn, in the sitting position, for analysis of akryloyl)-l-phenylalanyl-glycyl-glycine (FAPGG) routine laboratory parameters and different from which 3-(2-furyl-akryloyl)-l-phenylalanyl peptides/hormones. Prechilled test tubes of the (FAP) is formed, and its concentration is determined vacutainer type were used. For the ABP recordings by spectrophotometry. 15 CV was р8% for serum we used the 24-h ABP recorder Spacelab 90202 or ACE. 90207 (Spacelabs, Redmond, WA, USA). The monitor could be fitted with either a 12 or 15 cm wide armcuff, both of rectangular shape. We used the Statistics same cut-off limit of upper arm circumference for Statistical calculations were made using a Macinselection of armcuff as for the manual recordings of tosh personal computer and StatView 4.5 software. BP. The Spacelab automatic edit was used and BP Comparisons within and between groups were made measurement interval was set at 20 min throughout with Student's paired and unpaired two-tailed t-test the 24 h. ABP data were excluded from analysis if and correlations with Pearson's test. Mean ± s.d. are less than 70% successful BP readings during the day given unless otherwise stated. As the study was (06.00 to 23.00) or night (23.00 to 06.00) were designed prospectively to compare the designated recorded.
variables, no adjustment was made for multiple In 25 of the 224 participating subjects insufficient comparisons. Statistical significance was considered blood was obtained to permit all analyses and thus at the 5% level (P р 0.05). In statistical analyses the final study population presented here consisted with angiotensin II as a variable, values Ͻ2 pmol/l of 94 men and 105 women. Data on IRR were lost (level of sensitivity) were denoted as 1.0 (four cases). in a further four men and one woman for technical
The difference between r-values for PRA or IRR with reasons. In 30 subjects (18 women and 12 men), ABP angiotensin II was calculated after Fisher's Zwas incomplete (too many unsuccessful recordings, transformation had been done to accomplish normal mainly during the night). Men and women were distribution in those subjects in which the results of approximately evenly distributed between decades both PRA and IRR were available. Men vs women: *P р0.05, **P р0.01, ***P р0.0001. Mean ± s.d. IRR and ACE were lower in women than in men. Women (without oestrogen) 1.5 ± 0.9 9.5 ± 7.4 0.75 ± 0.25 9.9 ± 7.3
Women (oestrogen therapy) 2.2 ± 1.4** 7.6 ± 4.5 0.65 ± 0.19 8.5 ± 7.4 *P р 0.05, **P р 0.01, ***P р 0.0001. Mean ± s.d. PRA but not IRR was higher in women on oestrogen-therapy, although A-II levels were similar in women with or without oestrogen-therapy.
women. Plasma IRR and serum ACE were slightly with the level of angiotensin II (r = 0.20, P = 0.004). When calculated separately in men and women the lower in women than in men. Table 2 shows the RAS variables calculated separcorrelation was highly significant in men (r = 0.33, P = 0.001) but did not persist in women (r = 0.07, P ately in women with or without oestrogen therapy. PRA was higher among women on oestrogen ther-= 0.49). Figure 1 presents the correlation between ACE and angiotensin II in men. As the magnitude apy, although angiotensin II levels were not. Postmenopausal women (Ͼ55 years old) not on oesof the scatter of points about the regression line seem to be wider at higher ACE levels, the corretrogen replacement therapy had slightly lower PRA levels than men (women: 1.1 ± 0.68 ng Ang I/ml/h; lation was also tested with Spearman's non-parametric correlation which gave similar results (total men: 1.7 Ϯ 1.1 ng Ang I/ml/h, P = 0.017), but this difference did not remain after age adjustment (P = material: r = 0.17, P = 0.02; men: r = 0.32, P = 0.002; women: r = 0.02, P = 0.8). The correlation between 0.24). Women that were using contraceptive pills had higher PRA (pill-users: 2.7 ± 1.6 ng Ang I/ml/h; ACE and angiotensin II was unaffacted by the introduction of age and PRA as independent variables in users of oestrogen replacement-therapy: 1.1 ± 1.1 ng Ang I/ml/h, P = 0.046) but similar IRR levels (P = multivariate analysis (standardized r = 0.33, P = 0.001) but when PRA was exchanged for IRR in this 0.9) as those on oestrogen supplementation. The difference in PRA levels, however, disappeared after analysis, only a positive trend remained between ACE and angiotensin II (standardized r = 0.18, P = age adjustment (P = 0.98). Table 3 shows correlation coefficients between the 0.07). As this implied that ACE and IRR were not independent in men, the correlation between IRR components of the RAS. Values are given for the total material and separately calculated according to and ACE was calculated. In men ACE correlated to IRR, but no correlation was seen in women (men gender. As expected PRA and IRR had a reasonably high correlation coefficient (r = 0.60, P Ͻ 0.0001). The difference between the r-values for IRR or PRA to angiotensin II in women was statistically significant (men and women: P = 0.4; men: P = 0.4; women: P = 0.018).
In the total material ACE correlated positively 0.58*** Figure 1 Correlation between serum ACE activity (S-ACE) and *P р 0.05, **P р 0.01, ***P р0.0001. A-II = plasma angiotensin II.
plasma angiotensin II levels in men, n = 94, r = 0.33, P = 0.001. r = 0.26, P = 0.16; women, r = 0.08, P = 0.4). Neither between the RAS and BP. We do not believe that this was an artifact caused by a selection of subjects, ACE nor angiotensin II correlated with CBP, ABP or age.
as the participation rate was reasonably high in all age groups, and most non-participants gave the rea- Table 4 shows correlation coefficients for PRA and IRR with CBP, ABP and age. All significant correson 'lack of time' for not participating. We can not exclude, however, that the result would have been lations for PRA and IRR with CBP or ABP shown in this table (in women and in the total material) different had we not excluded subjects being treated for hypertension. The main reason for this design disappeared when multiple regression analysis was performed with age as a second independent variwas ethical, since we did not find it appropriate to discontinue medical treatment for at least a month able together with PRA or IRR. to achieve stable and unaffected BP and RAS variables. Possibly other results would have been found
Discussion
if we had measured sodium excretion in urine to which PRA and IRR could have been related. The We found a positive correlation between serum ACE activity and plasma angiotensin II levels, which to burden of urine collection probably would have caused a greater drop-out frequency, and generally our knowledge has not been shown before. On the contrary, ACE-activity has been assumed not to the compliance to achieve a complete urine collection can be questioned. Furthermore, in a previous affect the levels of angiotensin II. 16 The statistical significance of the correlation did not depend on a study in Linkö ping, no correlation was seen between sodium excretion and PRA in normotensive few outliers as it was similar when calculated by Spearman's non-parametric method. The D/D-genosubjects on a free diet, 20 and Rosei et al 21 have earlier shown that within the range of 100-200 mMol/ type of the I/D polymorphism of the ACE allele, is associated with high serum ACE activity. 2 This 24 h of sodium output there is no relation to PRA. In this study we confirm earlier reports that PRA genotype has been coupled to an adverse cardiovascular prognosis in many [3] [4] [5] but not all 6 studies. correlates negatively with BP 22 and that it declines with age. 20, [22] [23] [24] [25] [26] It has also been shown earlier that The correlation between ACE and angiotensin II in our study is consistent with the finding of Ueda et hypertension tends to develop into the 'low renin' type with age. 27 We found that the relationship al 17 that men with the D/D-genotype achieve higher angiotensin II levels during angiotensin I infusion between age and renin did not exist for IRR as it did for PRA which casts doubt on these theories. The than those with the II-genotype, although this was not verified by Lachurié et al. 18 most plausible explanation is that the decline in PRA with age was caused by a parallel decline in The functional activity of the renin-angiotensin system seems to be different between genders since plasma angiotensinogen levels resulting in a lower angiotensin I generation in the PRA analysis. 9,28 The there was no correlation between ACE and angiotensin II in women. The angiotensin I infusion study fact that angiotensin II levels were unaffacted by age, which is in accordance with earlier studies, 26, [29] [30] [31] [32] by Ueda only concerned men, 17 and other studies on ACE-gene-polymorphism and its relation to cardioalso suggests that the RAS is unaffacted by age in healthy subjects 20-70 years of age. There is a vascular prognosis or left ventricular hypertrophy have had a dominance of male subjects. [3] [4] [5] 19 As the debate whether to choose PRA or IRR for the measurement of the activity of the RAS 33-36 and our correlation between ACE and angiotensin II in men was not independent of IRR, the correlation between data suggest IRR to be at least as good as PRA. PRA was higher among oestrogen-treated women IRR and ACE was calculated and found to be statistically significant in men. This result should be interthan in women not taking this medication. The stimulating effect of oestrogen on angiotensinogen genpreted with some caution, however, as it had not been decided prospectively to perform this calcueration is well-known, 37 and it is reasonable to assume this to be the cause of higher PRA, but lation, but it is in accordance with the trend towards higher IRR levels in subjects with the D/D as comunchanged IRR levels, among oestrogen-treated women. There has been a long debate on whether pared to I/I ACE-allele in the studies by Lachurié et al 18 and Ueda et al.
17
PRA would be superior to IRR, or vice-versa, for the measurement of the activity of the RAS, 38,39 taking We found no age-independent correlations PRA and IRR correlated weakly negative with BP in women, when age-adjusted, however, these correlations did not persist. *P р0.05, **P р0.01, ***P р0.0001.
